MI

Mallikarjun Ishwarappa Pattanshetti

Active Director Designated Partner DIN 09512189
DIN 09512189 First appointment Feb 2022 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Mallikarjun Ishwarappa Pattanshetti

Data last updated:

Mallikarjun Ishwarappa Pattanshetti is a Designated Partner at Saiplus Pharma Llp (since 2022). The company operates in Business Services.

DIN 09512189
Primary Designation Designated Partner
Industry Business Services
First Appointment 22 Feb 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner22 Feb 20222022Active

Board colleagues of Mallikarjun Ishwarappa Pattanshetti

NameDINCompanyDesignation
Suryakant Mahadev Injal09515313Saiplus Pharma LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Saiplus Pharma Llp
Premium access

Shareholding and investment profile for Mallikarjun Ishwarappa Pattanshetti

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mallikarjun Ishwarappa Pattanshetti

Mallikarjun Ishwarappa Pattanshetti currently holds 1 directorship: Saiplus Pharma Llp (Designated Partner, since 22 Feb 2022).

Mallikarjun Ishwarappa Pattanshetti was first appointed on 22 Feb 2022 as Designated Partner at Saiplus Pharma Llp.

The current boards of Mallikarjun Ishwarappa Pattanshetti's companies include Suryakant Mahadev Injal (Saiplus Pharma Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available